Avita Medical is a medical device company that provides a unique approach to skin regeneration



The Company

Avita Medical is a medical device company that transforms lives through its unique and innovative skin regeneration solutions. We are a publicly listed, global medical technology company trading on the Australian Stock Exchange (ASX:AVH) and OTC Markets (OTCQX:AVMXY). We develop and distribute highly innovative regenerative products.

Our patented and proprietary collection and application technology provides innovative treatment solutions derived from a patient’s own skin to treat a wide range of wounds, scars and skin defects. Our devices create a Regenerative Epithelial Suspension (RES™) – an autologous suspension comprised of the cells and wound healing factors necessary to regenerate natural healthy skin.

Avita’s regenerative product portfolio includes ReCell® for burns aimed at plastic reconstructive procedures, ReGenerCell™ for chronic wounds and ReNovaCell™ for the restoration of pigmentation.

Read more



The Company

Avita Medical is a medical device company that transforms lives through its unique and innovative skin regeneration solutions. We are a publicly listed, global medical technology company trading on the Australian Stock Exchange (ASX:AVH) and OTC Markets (OTCQX:AVMXY). We develop and distribute highly innovative regenerative products.

Read more


7,694

Procedures

32

Market Approvals

64

Published Papers

ReCell® is a medical device that enables medical professionals to collect cells from a small sample of a patient’s own skin to create a suspension that can regenerate wounds.

Highlights

Facebook

follow

Avita Medical
Avita Medical added 5 new photos — in Barcelona, Spain.Thursday, September 7th, 2017 at 12:45am

Insightful presentations delivered by international ReCell surgeons; Dr. William Hickerson, US, Dr. James Holmes, US, Dr. Isabel Jones, UK and Dr. Simon Kuepper, DE at the ReCell Symposium held at the European Burns Association Congress in Barcelona, Spain. #eba2017

Avita Medical
Avita MedicalFriday, September 1st, 2017 at 3:09pm

‪A/Prof Greg Goodman & Dr Shobhan Manoharan discuss the use of ReCell in treating hypopigmentation at #ASCDsymposium

Share Price

Last Trade: 0.06 Last Trade: 1.07
High: 0.06 High: 1.11
Low: 0.06 Low: 1.0
Close: 0.06 Close: 1.1
Volume: 2,815,453 Volume: 44926
Prices are delayed by 20 minutes